首页 > 最新文献
paperpass

临床护理研究最新文献

英文 中文
Neonatal Brain Abscess: Case Report of 12 Cases and Literature Review 新生儿脑脓肿12例报告并文献复习
Pub Date : 2022-11-25 DOI: 10.26689/jcnr.v6i6.4451
Nan Peng, Zhimin Chen, Qi Lu
Objective: To investigate the etiological characteristics, clinical manifestations, and early identification methods of neonatal brain abscess. Methods: The baseline characteristics, clinical manifestations, and laboratory results of 12 neonatal brain abscess cases were retrospectively analyzed. Results: The clinical manifestations were fever, convulsion, and lethargy. A small number of them had respiratory and circulatory failure. The diagnosis made was based on imaging examination. All 12 cases were confirmed by cranial enhanced computed tomography (CT) or magnetic resonance imaging (MRI). Blood cultures of 9 cases were positive, with Escherichia coli in 6 cases, ?-hemolytic Streptococcus in 1 case, methicillin-resistant Staphylococcus aureus in 1 case, and Enterococcus faecium in 1 case. However, only 3 of them had positive cerebrospinal fluid (CSF) cultures. All the 12 neonates were treated with antibiotic therapy upon admission, with only 3 cases treated with surgery. Among them, 4 recovered and were discharged, while the remaining 8 discontinued their therapy. Conclusion: Escherichia coli is the most common pathogen of neonatal brain abscess in our study. The clinical manifestations of neonatal brain abscess are atypical, and the prognosis is poor. Respiratory and circulatory failure in children with intracranial infection may indicate the presence of brain abscess. For children with suspected brain abscess, cranial enhanced CT or MRI should be performed as soon as possible to make an early diagnosis. The prevention of brain abscess should be prioritized; neonates with sepsis or meningitis should receive prompt and strong antibiotic therapy in an effort to prevent the development of brain abscess.
目的:探讨新生儿脑脓肿的病因特点、临床表现及早期鉴别方法。方法:回顾性分析12例新生儿脑脓肿的基线特征、临床表现和实验室检查结果。结果:临床表现为发热、惊厥、嗜睡。其中一小部分患者出现呼吸和循环衰竭。诊断是基于影像学检查。所有12例均通过颅骨增强计算机断层扫描(CT)或磁共振成像(MRI)确诊。血培养阳性9例,大肠杆菌阳性6例-溶血性链球菌1例,耐甲氧西林金黄色葡萄球菌1例,粪肠球菌1例。然而,其中只有3人的脑脊液(CSF)培养呈阳性。所有12名新生儿入院时均接受抗生素治疗,只有3例接受了手术治疗。其中4人康复出院,其余8人停止治疗。结论:大肠杆菌是新生儿脑脓肿最常见的病原菌。新生儿脑脓肿的临床表现不典型,预后较差。颅内感染儿童的呼吸和循环衰竭可能表明存在脑脓肿。对于疑似脑脓肿的儿童,应尽快进行头颅增强CT或MRI检查,以便早期诊断。应优先预防脑脓肿;患有败血症或脑膜炎的新生儿应及时接受强有力的抗生素治疗,以防止脑脓肿的发展。
{"title":"Neonatal Brain Abscess: Case Report of 12 Cases and Literature Review","authors":"Nan Peng, Zhimin Chen, Qi Lu","doi":"10.26689/jcnr.v6i6.4451","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4451","url":null,"abstract":"Objective: To investigate the etiological characteristics, clinical manifestations, and early identification methods of neonatal brain abscess. Methods: The baseline characteristics, clinical manifestations, and laboratory results of 12 neonatal brain abscess cases were retrospectively analyzed. Results: The clinical manifestations were fever, convulsion, and lethargy. A small number of them had respiratory and circulatory failure. The diagnosis made was based on imaging examination. All 12 cases were confirmed by cranial enhanced computed tomography (CT) or magnetic resonance imaging (MRI). Blood cultures of 9 cases were positive, with Escherichia coli in 6 cases, ?-hemolytic Streptococcus in 1 case, methicillin-resistant Staphylococcus aureus in 1 case, and Enterococcus faecium in 1 case. However, only 3 of them had positive cerebrospinal fluid (CSF) cultures. All the 12 neonates were treated with antibiotic therapy upon admission, with only 3 cases treated with surgery. Among them, 4 recovered and were discharged, while the remaining 8 discontinued their therapy. Conclusion: Escherichia coli is the most common pathogen of neonatal brain abscess in our study. The clinical manifestations of neonatal brain abscess are atypical, and the prognosis is poor. Respiratory and circulatory failure in children with intracranial infection may indicate the presence of brain abscess. For children with suspected brain abscess, cranial enhanced CT or MRI should be performed as soon as possible to make an early diagnosis. The prevention of brain abscess should be prioritized; neonates with sepsis or meningitis should receive prompt and strong antibiotic therapy in an effort to prevent the development of brain abscess.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":"15 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41273248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation and Analysis of the Cognition of Menopause in Women Over 40 Years Old 40岁以上女性更年期认知状况的调查分析
Pub Date : 2022-11-25 DOI: 10.26689/jcnr.v6i6.4521
Meiping Chen, Ting Fang, Lu Chen, Rongrong Huang, Yangfang Tang
Objective: To investigate and analyze the cognition of menopause in women over 40 years old. Methods: Using the stratified sampling method, 224 females, age ranging from 40 to 60, from our university staff (Xi’an Medical University) and the surrounding communities were selected, and both online and offline questionnaires were distributed. Results: (1) 224 questionnaires were recovered, with 204 valid questionnaires, among which 100 questionnaires were from our university staff (aged 42–60 years old) and 104 questionnaires from the surrounding communities (aged 40–60 years old); (2) the cognition of menopause among the surveyed population was found to be related to occupation and education level; the cognition of menopause among university staff (76%) was significantly higher than that of the surrounding communities (45.19%); (3) most people were able to accept menopausal hormone therapy; the degree of acceptance among the university staff (80%) was found to be higher than that among the surrounding communities (60.58%). Conclusion: According to the recovered data, women over the age of 40 have less than ideal cognition of menopause, and although the cognitive level of the university staff on menopause was found to be significantly higher than that of the surrounding communities, their cognitive level still requires improvement.
目的:调查分析40岁以上妇女对更年期的认知情况。方法:采用分层抽样方法,从西安医科大学教职工及周边社区抽取224名40~60岁的女性进行问卷调查。结果:(1)共回收问卷224份,有效问卷204份,其中100份来自我校工作人员(42-60岁),104份来自周边社区(40-60岁);(2) 调查人群对更年期的认知与职业、文化程度有关;高校工作人员对更年期的认知程度(76%)显著高于周围社区(45.19%);(3) 大多数人能够接受更年期激素治疗;高校工作人员的接受程度(80%)高于周边社区(60.58%),他们的认知水平仍有待提高。
{"title":"Investigation and Analysis of the Cognition of Menopause in Women Over 40 Years Old","authors":"Meiping Chen, Ting Fang, Lu Chen, Rongrong Huang, Yangfang Tang","doi":"10.26689/jcnr.v6i6.4521","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4521","url":null,"abstract":"Objective: To investigate and analyze the cognition of menopause in women over 40 years old. Methods: Using the stratified sampling method, 224 females, age ranging from 40 to 60, from our university staff (Xi’an Medical University) and the surrounding communities were selected, and both online and offline questionnaires were distributed. Results: (1) 224 questionnaires were recovered, with 204 valid questionnaires, among which 100 questionnaires were from our university staff (aged 42–60 years old) and 104 questionnaires from the surrounding communities (aged 40–60 years old); (2) the cognition of menopause among the surveyed population was found to be related to occupation and education level; the cognition of menopause among university staff (76%) was significantly higher than that of the surrounding communities (45.19%); (3) most people were able to accept menopausal hormone therapy; the degree of acceptance among the university staff (80%) was found to be higher than that among the surrounding communities (60.58%). Conclusion: According to the recovered data, women over the age of 40 have less than ideal cognition of menopause, and although the cognitive level of the university staff on menopause was found to be significantly higher than that of the surrounding communities, their cognitive level still requires improvement.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49481672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Therapeutic Significance of Arsenite and Thalidomide in Patients with Myelodysplastic Syndrome 评价亚砷酸盐和沙利度胺治疗骨髓增生异常综合征的意义
Pub Date : 2022-11-25 DOI: 10.26689/jcnr.v6i6.4513
Y. Miao, Ying Gao
Objective: To analyze the therapeutic significance of arsenite and thalidomide in patients with myelodysplastic syndrome. Methods: From August 2021 to August 2022, 80 patients with myelodysplastic syndrome were selected and randomly divided into two groups. In the control group, the drug used was thalidomide tablets, whereas in the observation group, the drug used was arsenite and thalidomide. The treatment effect was observed and evaluated. Results: Before treatment, there was no statistical significance in the blood and serological indices between the two groups. After treatment, the observation group showed better blood and serological indices than the control group (P < 0.05). The clinical efficacy of the observation group was 77.5%, while that of the control group was 50.0%. The observation group had significantly better treatment effect (P < 0.05). The incidence of adverse effects in the observation group and the control group was 5.0% and 20.0%, respectively. The observation group had significantly fewer adverse effects (P < 0.05). Conclusion: In the treatment of patients with myelodysplastic syndrome, the use of arsenite on the basis of thalidomide can effectively improve the treatment effect and optimize the levels of various blood and serological indices, with fewer adverse effects and a relatively high safety profile.
目的:分析亚砷酸盐与沙利度胺治疗骨髓增生异常综合征的意义。方法:选取2021年8月~ 2022年8月80例骨髓增生异常综合征患者,随机分为两组。对照组用药为沙利度胺片,观察组用药为亚砷酸盐加沙利度胺。观察并评价治疗效果。结果:治疗前,两组患者血液及血清学指标比较,差异均无统计学意义。治疗后,观察组患者血液及血清学指标均优于对照组(P < 0.05)。观察组临床有效率为77.5%,对照组为50.0%。观察组治疗效果显著优于对照组(P < 0.05)。观察组和对照组不良反应发生率分别为5.0%和20.0%。观察组患者不良反应明显减少(P < 0.05)。结论:在沙利度胺基础上应用亚砷酸盐治疗骨髓增生异常综合征患者,可有效提高治疗效果,优化各项血液及血清学指标水平,且不良反应少,安全性较高。
{"title":"Evaluation of the Therapeutic Significance of Arsenite and Thalidomide in Patients with Myelodysplastic Syndrome","authors":"Y. Miao, Ying Gao","doi":"10.26689/jcnr.v6i6.4513","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4513","url":null,"abstract":"Objective: To analyze the therapeutic significance of arsenite and thalidomide in patients with myelodysplastic syndrome. Methods: From August 2021 to August 2022, 80 patients with myelodysplastic syndrome were selected and randomly divided into two groups. In the control group, the drug used was thalidomide tablets, whereas in the observation group, the drug used was arsenite and thalidomide. The treatment effect was observed and evaluated. Results: Before treatment, there was no statistical significance in the blood and serological indices between the two groups. After treatment, the observation group showed better blood and serological indices than the control group (P < 0.05). The clinical efficacy of the observation group was 77.5%, while that of the control group was 50.0%. The observation group had significantly better treatment effect (P < 0.05). The incidence of adverse effects in the observation group and the control group was 5.0% and 20.0%, respectively. The observation group had significantly fewer adverse effects (P < 0.05). Conclusion: In the treatment of patients with myelodysplastic syndrome, the use of arsenite on the basis of thalidomide can effectively improve the treatment effect and optimize the levels of various blood and serological indices, with fewer adverse effects and a relatively high safety profile.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45144597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-Analysis of the Efficacy of Cimetidine in the Treatment of Mumps 西咪替丁治疗腮腺炎疗效的meta分析
Pub Date : 2022-11-22 DOI: 10.26689/jcnr.v6i6.4479
Shiwei Wang, Chenyu Wang
Objective: To compare the efficacy of cimetidine and ribavirin in the treatment of mumps by meta-analysis. Methods: Controlled trials of cimetidine and ribavirin in the treatment of mumps were searched through China National Knowledge Infrastructure (CNKI), Wanfang data, Cqvip, Pubmed, The Cochrane Library and EMBase databases up to September 2022. The effective rate, the time of swelling regression in parotid gland area and the rate of adverse reactions were analyzed by Review Manager 5.3 software. Results: The final 10 articles included 920 children, including 427 in the trial group and 447 in the control group. Meta analysis showed that the effective rate of cimetidine in the treatment of mumps was higher than that of ribavirin in routine treatment, with a statistically significant difference (odds ratio [OR] = 5.2, P < 0.00001); The time of swelling regression was statistically significant (OR = -1.28, P < 0.00001); The difference of adverse reaction rate was not statistically significant (OR = 0.73, P = 0.62). Conclusions: Compared with ribavirin, cimetidine is more effective in the treatment of mumps, with shorter swelling regression time without increases of adverse reactions.
目的:通过荟萃分析比较西咪替丁与利巴韦林治疗腮腺炎的疗效。方法:检索截至2022年9月的中国知网(CNKI)、万方数据、Cqvip、Pubmed、the Cochrane Library和EMBase数据库中有关西咪替丁和利巴韦林治疗腮腺炎的对照试验。采用Review Manager 5.3软件分析有效率、腮腺肿大消退时间及不良反应发生率。结果:最终10篇文章纳入920名儿童,其中试验组427名,对照组447名。Meta分析显示,西咪替丁治疗腮腺炎的有效率高于常规治疗利巴韦林,差异有统计学意义(优势比[OR] = 5.2, P < 0.00001);肿胀回归时间有统计学意义(OR = -1.28, P < 0.00001);两组不良反应发生率差异无统计学意义(OR = 0.73, P = 0.62)。结论:与利巴韦林相比,西咪替丁治疗腮腺炎更有效,肿胀消退时间更短,且不良反应未增加。
{"title":"Meta-Analysis of the Efficacy of Cimetidine in the Treatment of Mumps","authors":"Shiwei Wang, Chenyu Wang","doi":"10.26689/jcnr.v6i6.4479","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4479","url":null,"abstract":"Objective: To compare the efficacy of cimetidine and ribavirin in the treatment of mumps by meta-analysis. Methods: Controlled trials of cimetidine and ribavirin in the treatment of mumps were searched through China National Knowledge Infrastructure (CNKI), Wanfang data, Cqvip, Pubmed, The Cochrane Library and EMBase databases up to September 2022. The effective rate, the time of swelling regression in parotid gland area and the rate of adverse reactions were analyzed by Review Manager 5.3 software. Results: The final 10 articles included 920 children, including 427 in the trial group and 447 in the control group. Meta analysis showed that the effective rate of cimetidine in the treatment of mumps was higher than that of ribavirin in routine treatment, with a statistically significant difference (odds ratio [OR] = 5.2, P < 0.00001); The time of swelling regression was statistically significant (OR = -1.28, P < 0.00001); The difference of adverse reaction rate was not statistically significant (OR = 0.73, P = 0.62). Conclusions: Compared with ribavirin, cimetidine is more effective in the treatment of mumps, with shorter swelling regression time without increases of adverse reactions.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44131841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Observation on the Clinical Effect of Stereotactic Body Radiotherapy in Patients with Oligometastatic Tumors 立体定向放射治疗低转移肿瘤的临床疗效观察
Pub Date : 2022-11-21 DOI: 10.26689/jcnr.v6i6.4429
Gaofei Zhang, Long Jin, Xin Chen, Hui Gao, Shaojun Ma, Zhuo Wu
Objective: To observe the efficacy and safety of stereotactic body radiotherapy (SBRT) in the treatment of extracranial oligometastases. Method: A retrospective analysis of 70 patients with extracranial oligometastasis of malignant tumors who underwent SBRT in our hospital (Shaanxi Provincial People’s Hospital) from January 2019 to December 2021 with ? 5 metastases, ?3 metastatic organs, and metastases with diameters of ? 5 cm. According to the clinical data of patients, the dose-fractionation mode of SBRT is mainly determined according to the pathology of the primary tumor, the location of the metastatic tumor, and the important structures around the tumor. The local control, survival and adverse reactions were observed. Results: A total of 219 oligometastatic lesions in 70 patients were treated with SBRT. The median follow-up time was 24 months (12–40 months). The local control rate (LCR) of all target lesions assessed 3 months after radiotherapy was 94.1%; the 1-, 2-, and 3-year LCRs were 88.6%, 74.6%, and 64.9%, respectively. The median progression-free survival (PFS) was 11.8 months (95% CI, 8.9–14.7 months), and the 1- and 2-year PFS rates were 48.6% and 32.6%, respectively; the median overall survival (OS) was 31.9 month (95% CI 26.0-37.8 months), the 1-year OS rate was 84.3%. The local control time, PFS, and OS of patients with metastases ? 3 cm were significantly better than those with metastases > 3 cm, and the differences were statistically significant (P < 0.05). Acute adverse reactions after SBRT treatment in oligometastatic patients were mainly bone marrow suppression and gastrointestinal reactions, with incidence rates of 48.98% and 30.61%, respectively; chronic adverse reactions were mainly pain (bone, muscle), radiation enteritis, and radiation pneumonitis, with incidence rates of 38.57%, 30.00%, and 24.29%, respectively. The treatment-related adverse reactions were mainly grade 1, which were all improved after symptomatic treatment, except for one patient with bone metastases from lung cancer who had grade 4 myelosuppression. No grade 4 or 5 adverse events occurred in the other patients. Conclusion: The application of SBRT in the treatment of extracranial oligometastases is safe, effective, and has high tolerability.
目的:观察立体定向放射治疗颅内少转移瘤的疗效和安全性。方法:对2019年1月至2021年12月在我院(陕西省人民医院)接受SBRT治疗的70例恶性肿瘤颅外少转移患者进行回顾性分析?5个转移?3个转移器官,直径为?5 cm。根据患者的临床数据,SBRT的剂量分级模式主要根据原发肿瘤的病理、转移肿瘤的位置以及肿瘤周围的重要结构来确定。观察局部控制、存活率和不良反应。结果:70例患者共有219个少转移病灶接受了SBRT治疗。中位随访时间为24个月(12-40个月)。放疗后3个月评估的所有靶病变的局部控制率(LCR)为94.1%;1年、2年和3年LCR分别为88.6%、74.6%和64.9%。中位无进展生存期(PFS)为11.8个月(95%CI,8.9-14.7个月),1年和2年PFS发生率分别为48.6%和32.6%;中位总生存期(OS)为31.9个月(95%CI 26.0-37.8个月),1年OS发生率为84.3%?3 cm组明显优于3 cm以上转移组,差异有统计学意义(P<0.05)。少转移患者SBRT治疗后的急性不良反应主要为骨髓抑制和胃肠道反应,发生率分别为48.98%和30.61%;慢性不良反应主要为疼痛(骨骼、肌肉)、放射性肠炎和放射性肺炎,发生率分别为38.57%、30.00%和24.29%。与治疗相关的不良反应主要为1级,除1例癌症骨转移患者骨髓抑制为4级外,其余均在症状治疗后得到改善。其他患者未发生4级或5级不良事件。结论:应用SBRT治疗颅外少转移瘤安全、有效,耐受性高。
{"title":"Observation on the Clinical Effect of Stereotactic Body Radiotherapy in Patients with Oligometastatic Tumors","authors":"Gaofei Zhang, Long Jin, Xin Chen, Hui Gao, Shaojun Ma, Zhuo Wu","doi":"10.26689/jcnr.v6i6.4429","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4429","url":null,"abstract":"Objective: To observe the efficacy and safety of stereotactic body radiotherapy (SBRT) in the treatment of extracranial oligometastases. Method: A retrospective analysis of 70 patients with extracranial oligometastasis of malignant tumors who underwent SBRT in our hospital (Shaanxi Provincial People’s Hospital) from January 2019 to December 2021 with ? 5 metastases, ?3 metastatic organs, and metastases with diameters of ? 5 cm. According to the clinical data of patients, the dose-fractionation mode of SBRT is mainly determined according to the pathology of the primary tumor, the location of the metastatic tumor, and the important structures around the tumor. The local control, survival and adverse reactions were observed. Results: A total of 219 oligometastatic lesions in 70 patients were treated with SBRT. The median follow-up time was 24 months (12–40 months). The local control rate (LCR) of all target lesions assessed 3 months after radiotherapy was 94.1%; the 1-, 2-, and 3-year LCRs were 88.6%, 74.6%, and 64.9%, respectively. The median progression-free survival (PFS) was 11.8 months (95% CI, 8.9–14.7 months), and the 1- and 2-year PFS rates were 48.6% and 32.6%, respectively; the median overall survival (OS) was 31.9 month (95% CI 26.0-37.8 months), the 1-year OS rate was 84.3%. The local control time, PFS, and OS of patients with metastases ? 3 cm were significantly better than those with metastases > 3 cm, and the differences were statistically significant (P < 0.05). Acute adverse reactions after SBRT treatment in oligometastatic patients were mainly bone marrow suppression and gastrointestinal reactions, with incidence rates of 48.98% and 30.61%, respectively; chronic adverse reactions were mainly pain (bone, muscle), radiation enteritis, and radiation pneumonitis, with incidence rates of 38.57%, 30.00%, and 24.29%, respectively. The treatment-related adverse reactions were mainly grade 1, which were all improved after symptomatic treatment, except for one patient with bone metastases from lung cancer who had grade 4 myelosuppression. No grade 4 or 5 adverse events occurred in the other patients. Conclusion: The application of SBRT in the treatment of extracranial oligometastases is safe, effective, and has high tolerability.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42167177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy Observation of Pre-Excitation Regimen in the Treatment of Refractory Relapsed Acute Non-Lymphocytic Leukemia 预激方案治疗难治性复发急性非淋巴细胞白血病的疗效观察
Pub Date : 2022-11-21 DOI: 10.26689/jcnr.v6i6.4440
Y. Miao
Objective: To explore the clinical effect of applying the pre-excitation regimen in the treatment of patients with refractory relapsed acute non-lymphocytic leukemia (ANLL). Methods: This research work was carried out in our hospital (Shaanxi Provincial People’s Hospital) from September 2021 to September 2022. A total of 50 cases were selected for this study, and all were given a pre-excitation treatment plan, mainly low-dose cytarabine, aclarithromycin, etoposide, granulocyte colony-stimulating factor, and more were implemented. The clinical intervention effect was then analyzed. Results: Among the 50 patients in this study, the results showed that the treatment was very effective for 22 cases, accounting for 44.00%; effective for 14 cases, accounting for 28.00%; and ineffective for 14 cases, accounting for 28.00%. The total rate of effectiveness was 72.00%. The hematopoietic system adverse reactions of the patients were mainly bone marrow suppression. All 50 patients had different degrees of blood count decline, among which some patients’ neutrophils were less than 0.5×109 /L. The median time was 7 days. Among them, 25 patients had infection problems, the incidence rate was 50.00%, the patient’s platelet count PLT < 20 × 109/L, and the median time was 10 days. At the same time, among the 50 patients in this study, 34 (68.00%) patients had symptoms such as loss of appetite, nausea, vomiting, and fatigue, 17 (34.00%) patients showed hair loss, mildly elevated transaminases were observed in 8 (16.00%) patients, and 11 (22.00%) patients had muscle soreness. Conclusion: In the treatment of patients with refractory complex acute non-lymphocytic leukemia, the application of pre-excitation regimen has a significant effect, which can improve the adverse symptoms of patients, reduce the incidence of adverse reactions, and promote the recovery of patients.
目的:探讨预激方案治疗难治性复发急性非淋巴细胞白血病(ANLL)的临床疗效。方法:本研究于2021年9月至2022年9月在我院(陕西省人民医院)进行。本研究共选择50例患者,均给予预激治疗方案,主要实施低剂量阿糖胞苷、阿克拉霉素、依托泊苷、粒细胞集落刺激因子等。分析临床干预效果。结果:在本研究的50例患者中,结果显示治疗有效22例,占44.00%;有效14例,占28.00%;无效14例,占28.00%。总有效率72.00%。患者的造血系统不良反应主要为骨髓抑制。50例患者均有不同程度的血细胞计数下降,其中部分患者中性粒细胞低于0.5×109/L。中位时间为7天。其中25例患者存在感染问题,发病率为50.00%,患者血小板计数PLT<20×109/L,中位时间为10天。同时,在本研究的50名患者中,34名(68.00%)患者出现食欲不振、恶心、呕吐和疲劳等症状,17名(34.00%)患者脱发,8名(16.00%)患者出现转氨酶轻度升高,11名(22.00%)患者肌肉酸痛。结论:在治疗难治性复杂型急性非淋巴细胞白血病患者中,应用预激方案效果显著,可以改善患者的不良症状,降低不良反应的发生率,促进患者的康复。
{"title":"Efficacy Observation of Pre-Excitation Regimen in the Treatment of Refractory Relapsed Acute Non-Lymphocytic Leukemia","authors":"Y. Miao","doi":"10.26689/jcnr.v6i6.4440","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4440","url":null,"abstract":"Objective: To explore the clinical effect of applying the pre-excitation regimen in the treatment of patients with refractory relapsed acute non-lymphocytic leukemia (ANLL). Methods: This research work was carried out in our hospital (Shaanxi Provincial People’s Hospital) from September 2021 to September 2022. A total of 50 cases were selected for this study, and all were given a pre-excitation treatment plan, mainly low-dose cytarabine, aclarithromycin, etoposide, granulocyte colony-stimulating factor, and more were implemented. The clinical intervention effect was then analyzed. Results: Among the 50 patients in this study, the results showed that the treatment was very effective for 22 cases, accounting for 44.00%; effective for 14 cases, accounting for 28.00%; and ineffective for 14 cases, accounting for 28.00%. The total rate of effectiveness was 72.00%. The hematopoietic system adverse reactions of the patients were mainly bone marrow suppression. All 50 patients had different degrees of blood count decline, among which some patients’ neutrophils were less than 0.5×109 /L. The median time was 7 days. Among them, 25 patients had infection problems, the incidence rate was 50.00%, the patient’s platelet count PLT < 20 × 109/L, and the median time was 10 days. At the same time, among the 50 patients in this study, 34 (68.00%) patients had symptoms such as loss of appetite, nausea, vomiting, and fatigue, 17 (34.00%) patients showed hair loss, mildly elevated transaminases were observed in 8 (16.00%) patients, and 11 (22.00%) patients had muscle soreness. Conclusion: In the treatment of patients with refractory complex acute non-lymphocytic leukemia, the application of pre-excitation regimen has a significant effect, which can improve the adverse symptoms of patients, reduce the incidence of adverse reactions, and promote the recovery of patients.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43215010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients with Shoulder Dysfunction After Mastectomy Can Benefit from Nurse-Assisted Home-Based Range of Motion Exercises 乳房切除术后肩部功能障碍的患者可以从护士辅助的家庭活动范围练习中获益
Pub Date : 2022-11-21 DOI: 10.26689/jcnr.v6i6.4382
Waqas Ahmed, F. Afzal
Background: Shoulder dysfunction is very common after mastectomy, and there is also less follow-up for physiotherapy services among patients with mastectomy. Objective: A study was conducted to determine the role of nurse-assisted home-based range of motion (ROM) exercises in patients with shoulder dysfunction after mastectomy. Methods: A pre- and post-interventional study design was used to collect data from 30 post-mastectomy patients. The subjects were selected on a voluntary basis. Informed consent was obtained from post-mastectomy patients who were discharged from different oncology hospitals in Pakistan prior to their inclusion in this study. After obtaining a baseline measurement, the patients were supervised with nurse-assisted ROM exercises at home. The nurse-assisted home-based ROM exercise program was designed for such patients, and the patients were followed-up for up to 1 month. The total duration of the study was 1 year from August 2015 to August 2016. Post-intervention measurement was performed at the patients’ home. The difference in terms of pain reduction and ROM improvement at the shoulder joint was recorded using goniometric measurements and the 100 mm visual analogue scale (VAS). Results: The mean age of the 30 subjects was 39.83 ± 5.89. The mean ROM of shoulder flexion before the exercise program was 106.03°, which improved to 133.93° after 1 month of the exercise program. The mean ROM of shoulder abduction before treatment was 94.83°, which improved to 127.13° after 1 month of supervised exercise program. The mean ROM of shoulder rotation before the exercise program was 127.53°, which improved to 152.03° after 1 month of the exercise program. Conclusion: The nurse-assisted home-based shoulder ROM exercise program is effective in terms of improving the range of motion and reducing pain at the shoulder joint in post-mastectomy patients.
背景:乳房切除术后肩关节功能障碍非常常见,并且在乳房切除术患者中对物理治疗服务的随访较少。目的:进行一项研究,以确定护士辅助的家庭活动范围(ROM)运动在乳房切除术后肩关节功能障碍患者中的作用。方法:采用介入前和介入后研究设计,收集30例乳房切除术后患者的资料。研究对象是自愿选择的。在纳入本研究之前,从巴基斯坦不同肿瘤医院出院的乳房切除术后患者获得了知情同意。在获得基线测量后,患者在家中进行护士辅助的ROM练习。针对此类患者设计了护士辅助的居家ROM运动方案,并对患者进行了长达1个月的随访。研究总时间为1年,从2015年8月至2016年8月。干预后测量在患者家中进行。肩关节疼痛减轻和ROM改善方面的差异采用角度测量和100 mm视觉模拟量表(VAS)记录。结果:30例患者平均年龄39.83±5.89岁。运动前肩部屈曲的平均ROM为106.03°,运动1个月后改善为133.93°。治疗前肩关节外展的平均ROM为94.83°,经过1个月的监督运动后改善为127.13°。运动前肩关节旋转的平均ROM为127.53°,运动1个月后改善为152.03°。结论:护士辅助的家庭肩关节ROM运动方案在提高乳房切除术后肩关节活动度和减轻疼痛方面是有效的。
{"title":"Patients with Shoulder Dysfunction After Mastectomy Can Benefit from Nurse-Assisted Home-Based Range of Motion Exercises","authors":"Waqas Ahmed, F. Afzal","doi":"10.26689/jcnr.v6i6.4382","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4382","url":null,"abstract":"Background: Shoulder dysfunction is very common after mastectomy, and there is also less follow-up for physiotherapy services among patients with mastectomy. Objective: A study was conducted to determine the role of nurse-assisted home-based range of motion (ROM) exercises in patients with shoulder dysfunction after mastectomy. Methods: A pre- and post-interventional study design was used to collect data from 30 post-mastectomy patients. The subjects were selected on a voluntary basis. Informed consent was obtained from post-mastectomy patients who were discharged from different oncology hospitals in Pakistan prior to their inclusion in this study. After obtaining a baseline measurement, the patients were supervised with nurse-assisted ROM exercises at home. The nurse-assisted home-based ROM exercise program was designed for such patients, and the patients were followed-up for up to 1 month. The total duration of the study was 1 year from August 2015 to August 2016. Post-intervention measurement was performed at the patients’ home. The difference in terms of pain reduction and ROM improvement at the shoulder joint was recorded using goniometric measurements and the 100 mm visual analogue scale (VAS). Results: The mean age of the 30 subjects was 39.83 ± 5.89. The mean ROM of shoulder flexion before the exercise program was 106.03°, which improved to 133.93° after 1 month of the exercise program. The mean ROM of shoulder abduction before treatment was 94.83°, which improved to 127.13° after 1 month of supervised exercise program. The mean ROM of shoulder rotation before the exercise program was 127.53°, which improved to 152.03° after 1 month of the exercise program. Conclusion: The nurse-assisted home-based shoulder ROM exercise program is effective in terms of improving the range of motion and reducing pain at the shoulder joint in post-mastectomy patients.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48888520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Influencing Factors of Preeclampsia on Postpartum Hemorrhage 子痫前期对产后出血的影响因素分析
Pub Date : 2022-11-21 DOI: 10.26689/jcnr.v6i6.4367
Zhen Han, Ligong Zhu
Postpartum hemorrhage is a serious complication of preeclampsia. The main influencing factors of Preeclampsia on postpartum hemorrhage include vascular disease, trophoblast differentiation and infiltration disorder, the influence of antispasmodic, sedative and antihypertensive drugs, the incidence of hypertensive disorder complicating pregnancy related to calcium deficiency, coagulation dysfunction, and decreased blood volume during pregnancy. In recent years, postpartum hemorrhage has been the leading cause of maternal death in the world. Therefore, it is critical to understand the influencing factors of preeclampsia on postpartum hemorrhage. Based on the research and guidelines of preeclampsia and postpartum hemorrhage in recent years, this paper analyzes the influencing factors of preeclampsia on postpartum hemorrhage, and provides new ideas for clinical reduction of postpartum hemorrhage.
产后出血是先兆子痫的严重并发症。先兆子痫对产后出血的主要影响因素包括血管疾病、滋养层分化和浸润障碍、抗痉挛、镇静和降压药物的影响、与缺钙有关的妊娠期高血压障碍的发生率、凝血功能障碍和妊娠期血容量下降。近年来,产后出血一直是世界上孕产妇死亡的主要原因。因此,了解先兆子痫对产后出血的影响因素至关重要。根据近年来对先兆子痫和产后出血的研究和指南,分析先兆子痫对产后出血的影响因素,为临床减少产后出血提供新思路。
{"title":"Analysis of Influencing Factors of Preeclampsia on Postpartum Hemorrhage","authors":"Zhen Han, Ligong Zhu","doi":"10.26689/jcnr.v6i6.4367","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4367","url":null,"abstract":"Postpartum hemorrhage is a serious complication of preeclampsia. The main influencing factors of Preeclampsia on postpartum hemorrhage include vascular disease, trophoblast differentiation and infiltration disorder, the influence of antispasmodic, sedative and antihypertensive drugs, the incidence of hypertensive disorder complicating pregnancy related to calcium deficiency, coagulation dysfunction, and decreased blood volume during pregnancy. In recent years, postpartum hemorrhage has been the leading cause of maternal death in the world. Therefore, it is critical to understand the influencing factors of preeclampsia on postpartum hemorrhage. Based on the research and guidelines of preeclampsia and postpartum hemorrhage in recent years, this paper analyzes the influencing factors of preeclampsia on postpartum hemorrhage, and provides new ideas for clinical reduction of postpartum hemorrhage.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49506084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Efficacy of Western Medicine Combined with Chinese Medicine for Pelvic Inflammatory Disease (Damp-Heat and Stasis Type) 中西医结合治疗盆腔炎(湿热瘀型)临床疗效观察
Pub Date : 2022-11-21 DOI: 10.26689/jcnr.v6i6.4345
Yao Chen, Yu Cao, Huifang Li
Objective: This study was undertaken to evaluate the clinical efficacy of Western medicine combined with Chinese medicine for pelvic inflammatory disease (damp-heat and stasis type). Methods: Seventy-four patients who were diagnosed with pelvic inflammatory disease (damp-heat and stasis type) by our hospital during July 2021 to July 2022 were randomized into two groups: the participants in the control group received conventional Western medicine treatment, and the participants in the study group received Western medicine combined with Chinese medicine. Results: After treatment, the total effectiveness of the control group (72.98%) was significantly lower than that of the study group (94.59%), (P < 0.05); the whole blood viscosity high cut, whole blood viscosity low cut, fibrinogen and plasma viscosity of the control group were all lower than those of the study group (P < 0.05); the levels of CRP, IL-6, and TNF-? in the control group were higher and IL-2 levels in the control group were lower than those in the study group (P < 0.05). Conclusion: Western medicine combined with Chinese medicine is more effective in curing damp-heat and stasis-type pelvic inflammatory disease by improving the blood rheological indexes and lowering the level of inflammatory factors.
目的:探讨中西医结合治疗盆腔炎(湿热瘀型)的临床疗效。方法:选取我院于2021年7月至2022年7月诊断为盆腔炎(湿热瘀型)的74例患者,随机分为两组,对照组采用西医常规治疗,研究组采用中西医结合治疗。结果:治疗后,对照组总有效率(72.98%)显著低于研究组总有效率(94.59%),差异有统计学意义(P < 0.05);对照组全血黏度高切、全血黏度低切、纤维蛋白原、血浆黏度均低于研究组(P < 0.05);CRP, IL-6和TNF-的水平?对照组患者IL-2水平低于研究组,差异有统计学意义(P < 0.05)。结论:中西医结合可改善血液流变学指标,降低炎症因子水平,治疗湿热瘀型盆腔炎疗效显著。
{"title":"Clinical Efficacy of Western Medicine Combined with Chinese Medicine for Pelvic Inflammatory Disease (Damp-Heat and Stasis Type)","authors":"Yao Chen, Yu Cao, Huifang Li","doi":"10.26689/jcnr.v6i6.4345","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4345","url":null,"abstract":"Objective: This study was undertaken to evaluate the clinical efficacy of Western medicine combined with Chinese medicine for pelvic inflammatory disease (damp-heat and stasis type). Methods: Seventy-four patients who were diagnosed with pelvic inflammatory disease (damp-heat and stasis type) by our hospital during July 2021 to July 2022 were randomized into two groups: the participants in the control group received conventional Western medicine treatment, and the participants in the study group received Western medicine combined with Chinese medicine. Results: After treatment, the total effectiveness of the control group (72.98%) was significantly lower than that of the study group (94.59%), (P < 0.05); the whole blood viscosity high cut, whole blood viscosity low cut, fibrinogen and plasma viscosity of the control group were all lower than those of the study group (P < 0.05); the levels of CRP, IL-6, and TNF-? in the control group were higher and IL-2 levels in the control group were lower than those in the study group (P < 0.05). Conclusion: Western medicine combined with Chinese medicine is more effective in curing damp-heat and stasis-type pelvic inflammatory disease by improving the blood rheological indexes and lowering the level of inflammatory factors.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47866957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nursing Effect of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease 慢性阻塞性肺疾病患者肺康复的护理效果
Pub Date : 2022-11-16 DOI: 10.26689/jcnr.v6i6.4506
Qiming Cheng, Fei Lai, Liu Yang, Shuang Long, Ruyang Song
Objective: To study the effect of pulmonary rehabilitation nursing in nursing of patients with chronic obstructive pulmonary disease (COPD). Methods: 30 cases of experimental subjects, diagnosed with COPD, were included in the observation group with pulmonary rehabilitation nursing, while the control group received routine nursing, and the data between the groups were compared. Results: After nursing, the observation group showed significantly improved lung function, higher nursing satisfaction, 6-minute walking test (6WMT), World Health Organization Quality of Life (WHOQOL-BREF) score, and self-care ability score, compared to the control group, with P < 0.05, indicating a statistical difference. Conclusion: Pulmonary rehabilitation nursing is applied in the nursing of COPD patients with ideal effect.
目的:探讨肺康复护理在慢性阻塞性肺疾病(COPD)患者护理中的作用。方法:将30例确诊为COPD的实验对象纳入观察组,给予肺康复护理,对照组给予常规护理,比较两组数据。结果:护理后,观察组患者肺功能、护理满意度、6分钟步行测试(6WMT)、世界卫生组织生活质量评分(WHOQOL-BREF)、生活自理能力评分均较对照组显著改善,P < 0.05,差异有统计学意义。结论:将肺康复护理应用于慢性阻塞性肺病患者的护理中,效果理想。
{"title":"Nursing Effect of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease","authors":"Qiming Cheng, Fei Lai, Liu Yang, Shuang Long, Ruyang Song","doi":"10.26689/jcnr.v6i6.4506","DOIUrl":"https://doi.org/10.26689/jcnr.v6i6.4506","url":null,"abstract":"Objective: To study the effect of pulmonary rehabilitation nursing in nursing of patients with chronic obstructive pulmonary disease (COPD). Methods: 30 cases of experimental subjects, diagnosed with COPD, were included in the observation group with pulmonary rehabilitation nursing, while the control group received routine nursing, and the data between the groups were compared. Results: After nursing, the observation group showed significantly improved lung function, higher nursing satisfaction, 6-minute walking test (6WMT), World Health Organization Quality of Life (WHOQOL-BREF) score, and self-care ability score, compared to the control group, with P < 0.05, indicating a statistical difference. Conclusion: Pulmonary rehabilitation nursing is applied in the nursing of COPD patients with ideal effect.","PeriodicalId":64151,"journal":{"name":"临床护理研究","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47850711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
临床护理研究
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1